Sesen Bio Inc.
SESN
Get informed when a big investor buys or sells
+ FollowMarket Cap$127.96M
Close$
Share Statistics
| Market cap | $127.96 Million |
|---|---|
| Enterprise Value | $125.94 Million |
| Dividend Yield | $- (57.25%) |
| Earnings per Share | $-1.46 |
| Beta | 0.83 |
| Outstanding Shares | 41,788,096 |
Return
| Return on Equity | -3589.50% |
|---|---|
| Return on Assets | 474.84% |
| Return on Invested Capital | -18920.16% |
Valuation & Multiples
| P/E Ratio | 0.84 |
|---|---|
| PEG | -0.19 |
| Price to Sales | -0.63 |
| Price to Book Ratio | -0.63 |
| Enterprise Value to Revenue | -11.85 |
| Enterprise Value to EBIT | 2.58 |
| Enterprise Value to Net Income | 4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.88 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sesen Bio Inc.
CEO: Thomas Cannell